Skip to main content
Log in

Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated parkinson's disease

  • Original Investigations
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Plasma profiles of prolactin, growth hormone, adrenocorticotropic hormone (ACTH) and cortisol were evaluated in a group of untreated patients with idiopathic Parkinson's disease and a group of healthy age-matched controls. Plasma integrated concentrations of all hormones except prolactin were significantly lower in the patients as compared with the controls; however, prolactin nocturnal peak concentration was significantly elevated in the patients; nocturnal growth hormone levels were significantly reduced in the Parkinson group; ACTH and cortisol plasma concentrations were also consistently lower during most of the day in the patients with Parkinson's disease. These data confirm the presence of a hypothalamic disturbance in patients with idopathic Parkinson's disease, which can affect pituitary function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Al Damluj S, Iveson T, Thomas JM, Pendlebury DJ, Rees LM, Besser GM (1987) Food induced cortisol secretion is mediated by central alpha-1-adrenoceptormodulation of pituitary ACTH secretion. Clin Endocrinol 26:629–636

    Google Scholar 

  2. Bernheimer N, Birkmayer W, Hornykiewicz O (1963) Zur Biochemie des Parkinson Syndroms des Menschen. Klin Wochenschr 410:465–469

    Google Scholar 

  3. Birkmayer W, Danielczyk W, Neumayer E, Riederer P (1974) Nucleus ruber and l-Dopa psychosis. J Neural Transm 35:93–116

    Google Scholar 

  4. Blichert-Toft M (1975) Corticotrophin secretion in old age. Acta Endocrinol (Copenh) [Suppl 195] 78:1–155

    Google Scholar 

  5. Brown WA, Van Woert MH, Ambani LM (1973) Effect of apomorphine on growth hormone release in humans. J Clin Endocrinol Metab 37:463–465

    Google Scholar 

  6. Conte-Devolx B, Grino M, Nieoullon A, Javoy-Agid F, Castanas E, Guillaume V, Tonon MC, Vaudry H, Oliver C (1985) Corticocoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus. Neurosci Lett 56:217–222

    Google Scholar 

  7. Conte-Devolx B, Pfister B, Viallet F, Rey M, Conte-Devolx J (1987) La fonction endocrine ante-hypophysaire dans la maladie de Parkinson. Presse Med 16:566–568

    Google Scholar 

  8. Eisler T, Thorner MO, MacLeod RM, Kaiser DL, Calne DB (1981) Prolactin secretion in Parkinson disease. Neurology 31:1365–1369

    Google Scholar 

  9. Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916–918

    Google Scholar 

  10. Ewing DJ, Campbell IW, Clarke BF (1980) Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 92:308–311

    Google Scholar 

  11. Ganong WF (1980) Neurotransmitter and pituitary function: regulation of ACTH secretion. Fed Proc 39:2923–2930

    Google Scholar 

  12. Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18:925–964

    Google Scholar 

  13. Javoy-Agid F, Ruberg L, Pique L, Bertagna X, Taquet H, Studler JM, Cesselin F, Epelbaum J, Agid Y (1984) Biochemistry of the hypothalamus in Parkinson's disease. Neurology 34:672–675

    Google Scholar 

  14. Jones MT, Gillham B, Campbell EA, Al-Taber ARH, Chuang TT, Di Sciullo A (1987) Pharmacology of neural pathways affecting CRH secretion. In: Ganong FW, Dallman MF, Roberts JL (eds) The hypothalamic-pituitary-adrenal axis revisited. Ann N Y Acad Sci 512:162–175

    Google Scholar 

  15. Kebabian JW, Calne DB (1979) Multiple receptor mechanism for dopamine. Nature 227:93–96

    Google Scholar 

  16. Langston JS, Forno LS (1978) The hypothalamus in Parkinson's disease. Ann Neurol 3:129–133

    Google Scholar 

  17. Martinez-Campos A, Giovannini P, Novelli A, Cocci D, Caraceni T, Müller EE (1982) Thyrotropin and prolactin responses to thyrotropin releasing hormone in patients with Parkinson's disease. Acta Endocrinol (Copenh) 99:344–351

    Google Scholar 

  18. Micieli G, Martignoni E, Cavallini A, Sandrini G, Nappi G (1987) Postprandial and orthostatic hypotension in Parkinson's disease. Neurology 37:386–393

    Google Scholar 

  19. Milsom SR, Conaglen JV, Donald PA, Espiner FP, Nicholls G, Livesey JH (1986) The effect of peripheral catecholamine concentrations on the pituitary adrenal response to corticotrophin releasing factor in man. Clin Endocrinol 25:241–246

    Google Scholar 

  20. Murri L, Indice A, Muratorio A, Pollere A, Barreca T, Murialdo G (1980) Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea. Eur Neurol 19:198–206

    Google Scholar 

  21. Nathan RS, Sachar EJ, Ostrow L, Asnis GM, Halbreich U, Halpern FS (1981) Failure of dopaminergic blockade to affect prolactin, growth hormone and cortisol response to insulin-induced hypoglycemia in schizophrenics. J Clin Endocrinol Metab 52:807–809

    Google Scholar 

  22. Riederer P, Wuketich S (1976) Time course of nigro-striatal degeneration in Parkinson's disease. J Neural Transm 38:377–382

    Google Scholar 

  23. Rodbard D (1974) Statistical quality control and routine data processing for radioimmunoassay and immunoradiometric assays. Clin Chem 20:1255–1270

    Google Scholar 

  24. Vogel HP, Ketsche R (1986) Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin thyrotropin and cortisol in Parkinson's disease before and during therapy. J Neurol 233:149–152

    Google Scholar 

  25. Williams TDM, Lightman SM, Johnson MR, Carmichael DJS, Bannister R (1989) Selective defect in gonadotrophin secretion in patients with autonomic failure. Clin Endocrinol 30:285–292

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellomo, G., Santambrogio, L., Fiacconi, M. et al. Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated parkinson's disease. J Neurol 238, 19–22 (1991). https://doi.org/10.1007/BF00319704

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00319704

Key words

Navigation